Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of June 2025. The report specifically details a transaction in own shares executed under the company's share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide comprehensive financial statements such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share repurchase activity on June 5, 2025:
- Shares Purchased: 831,366 ordinary shares
- Highest Price Paid: 404.90 pence per share
- Lowest Price Paid: 397.80 pence per share
- Volume Weighted Average Price: 402.80 pence per share
- Post-Transaction Share Capital: 9,002,093,567 ordinary shares
- Treasury Shares Held: 4,080,205
- Voting Shares Outstanding: 8,998,013,362
Material Changes
The primary material change reported is the reduction of the company's share count through the cancellation of 831,366 shares. This action reduces the number of ordinary shares with voting rights to 8,998,013,362. No other material changes to operations or financial position are disclosed in this specific filing.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or discussion of risks and contingencies. It is a routine disclosure of a share buyback transaction in compliance with the Market Abuse Regulation (Article 5(1)(b) of Regulation (EU) No 596/2014).
Key Facts for Investor Verification
- Verify the total number of shares repurchased to date under the March 28, 2025 Buyback Programme.
- Confirm the current market price of Haleon shares relative to the 402.80 pence average purchase price.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular transaction details.
- Check subsequent filings for updates on the remaining authorization under the buyback programme.